Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.65 USD | +1.61% | +2.67% | -11.14% |
Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Apr. 09 | Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study | MT |
Financials (USD)
Sales 2024 * | 1.52B | Sales 2025 * | 1.52B | Capitalization | 4.1B |
---|---|---|---|---|---|
Net income 2024 * | 352M | Net income 2025 * | 331M | EV / Sales 2024 * | 2.18 x |
Net cash position 2024 * | 791M | Net cash position 2025 * | 1.17B | EV / Sales 2025 * | 1.92 x |
P/E ratio 2024 * |
12.1
x | P/E ratio 2025 * |
13.3
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.59% |
Latest transcript on Alkermes plc
1 day | +1.61% | ||
1 week | +3.70% | ||
Current month | -8.94% | ||
1 month | -9.67% | ||
3 months | -13.63% | ||
6 months | +0.90% | ||
Current year | -11.14% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Blair Jackson
DFI | Director of Finance/CFO | 51 | 98-12-31 |
Shane Cooke
PSD | President | 61 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 16-05-25 |
Brian McKeon
BRD | Director/Board Member | 61 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.32% | 215 M€ | +11.68% | - | |
2.65% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 24.65 | +1.61% | 1,737,019 |
24-04-23 | 24.26 | +0.79% | 1,245,764 |
24-04-22 | 24.07 | +0.92% | 1,708,265 |
24-04-19 | 23.85 | +0.38% | 2,414,813 |
24-04-18 | 23.76 | -1.04% | 1,798,839 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.14% | 4.1B | |
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |
- Stock Market
- Equities
- ALKS Stock